Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: GeneNews; Fluidigm; MDS, Promega; AnaSpec

NEW YORK (GenomeWeb News) – GeneNews said this week that it will receive a grant of MYR 5 million (US$1.4 million) from the Malaysian Ministry of Health for a two-year project focused on developing blood-based diagnostic tests for liver cancer, hepatitis B, and nasopharyngeal cancer based on the firm's Sentinel Principle platform.


Fluidigm said that Enza Zaden, a supplier of vegetable seeds for agriculture, has chosen the firm's BioMark System for Genetic Engineering and the 96.96 Dynamic Array to ensure the quality of its feed supply.


MDS Analytical Technologies said this week that its SpectraMax L microplate luminometers have received Dual-Luciferase Reporter Assay certification from Promega. The certification confirms that MDS' luminometers meet Promega's performance criteria for the DLR assay.


AnaSpec announced that it had launched its new headquarter in Fremont, Calif. It said that all of its divisions would be housed within the 44,010-square-feet facility.